{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T07:14:41Z","timestamp":1791616481606,"version":"4.3.4"},"reference-count":80,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1097\/ogx.0b013e31817f1585","type":"journal-article","created":{"date-parts":[[2008,8,20]],"date-time":"2008-08-20T07:06:50Z","timestamp":1219216010000},"page":"585-596","source":"Crossref","is-referenced-by-count":22,"title":["Pharmaceutical Industry Marketing: Understanding Its Impact on Women\u2019s Health"],"prefix":"10.1097","volume":"63","author":[{"given":"Carolyn B.","family":"Sufrin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph S.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-21-20210212","article-title":"Pharmaceutical Industry Profile 2007.","year":"2007"},{"key":"R4-21-20210212","article-title":"Global Pharmaceutical Perspectives 2006.","year":"2006"},{"key":"R5-21-20210212","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1371\/journal.pmed.0050001","article-title":"The cost of pushing pills: a new estimate of pharmaceutical promotion expenditures in the United States.","volume":"3","author":"Gagnon","year":"2008","journal-title":"PLoS Med"},{"key":"R9-21-20210212","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1056\/NEJMsa070502","article-title":"A decade of direct-to-consumer advertising of prescription drugs.","volume":"357","author":"Donohue","year":"2007","journal-title":"N Engl J Med"},{"key":"R10-21-20210212","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1370\/afm.611","article-title":"Creating demand for prescription drugs: a content analysis of television direct-to-consumer advertising.","volume":"5","author":"Frosch","year":"2007","journal-title":"Ann Fam Med"},{"key":"R11-21-20210212","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.amjmed.2006.09.030","article-title":"Direct-to-consumer advertising of pharmaceuticals.","volume":"120","author":"Gellad","year":"2007","journal-title":"Am J Med"},{"key":"R15-21-20210212","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1056\/NEJMp048357","article-title":"To inform or persuade? Direct-to-consumer advertising of prescription drugs.","volume":"352","author":"Berndt","year":"2005","journal-title":"N Engl J Med"},{"key":"R17-21-20210212","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1056\/NEJM200202143460713","article-title":"Direct-to-consumer advertising\u2013education or emotion promotion?","volume":"346","author":"Wolfe","year":"2002","journal-title":"N Engl J Med"},{"key":"R18-21-20210212","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/archinte.164.4.427","article-title":"Direct-to-consumer pharmaceutical advertising: physician and public opinion and potential effects on the physician-patient relationship.","volume":"164","author":"Robinson","year":"2004","journal-title":"Arch Intern Med"},{"key":"R20-21-20210212","article-title":"Patient and Physician Attitudes and Behaviors Associated with Direct to Consumer Promotion of Prescription Drugs: Summary of FDA Survey Research Results.","author":"Aikin","year":"2004"},{"key":"R21-21-20210212","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1001\/jama.284.17.2240-JMS1101-1-2","article-title":"MSJAMA. The rise of direct-to-consumer advertising of prescription drugs in the United States.","volume":"284","author":"Huang","year":"2000","journal-title":"JAMA"},{"key":"R22-21-20210212","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1300\/J026v22n04_03","article-title":"Pharmaceutical drug marketing strategies and tactics: a comparative analysis of attitudes held by pharmaceutical representatives and physicians.","volume":"22","author":"Parker","year":"2005","journal-title":"Health Mark Q"},{"key":"R23-21-20210212","first-page":"495","article-title":"The opinions and experiences of family physicians regarding direct-to-consumer advertising.","volume":"45","author":"Lipsky","year":"1997","journal-title":"J Fam Pract"},{"key":"R24-21-20210212","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3122\/jabfm.16.6.513","article-title":"Direct-to-consumer advertising: physicians\u2019 views of its effects on quality of care and the doctor-patient relationship.","volume":"16","author":"Murray","year":"2003","journal-title":"J Am Board Fam Pract"},{"key":"R25-21-20210212","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1097\/00005650-200412000-00004","article-title":"Effects of pharmaceutical promotion on adherence to the treatment guidelines for depression.","volume":"42","author":"Donohue","year":"2004","journal-title":"Med Care"},{"key":"R26-21-20210212","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1001\/jama.293.16.1995","article-title":"Influence of patients\u2019 requests for direct-to-consumer advertised antidepressants: a randomized controlled trial.","volume":"293","author":"Kravitz","year":"2005","journal-title":"JAMA"},{"key":"R27-21-20210212","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1177\/1077558705279314","article-title":"Direct-to-consumer advertising of COX-2 inhibitors: effect on appropriateness of prescribing.","volume":"62","author":"Spence","year":"2005","journal-title":"Med Care Res Rev"},{"key":"R28-21-20210212","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1136\/bmj.324.7332.278","article-title":"Influence of direct to consumer pharmaceutical advertising and patients\u2019 requests on prescribing decisions: two site cross sectional survey.","volume":"324","author":"Mintzes","year":"2002","journal-title":"BMJ"},{"key":"R29-21-20210212","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1377\/hlthaff.25.5.1371","article-title":"How direct-to-consumer television advertising for osteoarthritis drugs affects physicians\u2019 prescribing behavior.","volume":"25","author":"Bradford","year":"2006","journal-title":"Health Aff (Millwood)"},{"key":"R30-21-20210212","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0029-7844(97)00059-8","article-title":"Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: a randomized, placebo-controlled trial.","volume":"89","author":"Redmond","year":"1997","journal-title":"Obstet Gynecol"},{"key":"R31-21-20210212","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.contraception.2005.07.010","article-title":"Treating acne with oral contraceptives: use of lower doses.","volume":"73","author":"Huber","year":"2006","journal-title":"Contraception"},{"key":"R34-21-20210212","first-page":"44","article-title":"The Top 200: what\u2019s making waves in prescription sales.","volume":"22","author":"Cavallucci","year":"2006","journal-title":"Pharmacy Practice"},{"key":"R35-21-20210212","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1056\/NEJMp048286","article-title":"Failing the public health\u2014rofecoxib, Merck, and the FDA.","volume":"351","author":"Topol","year":"2004","journal-title":"N Engl J Med"},{"key":"R36-21-20210212","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/bmj.39024.487720.68","article-title":"What have we learnt from Vioxx?","volume":"334","author":"Krumholz","year":"2007","journal-title":"BMJ"},{"key":"R39-21-20210212","article-title":"Disease-Mongers: How Doctors, Drug Companies, and Insurers are Making You Feel Sick.","author":"Payer","year":"1992"},{"key":"R41-21-20210212","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1136\/bmj.324.7342.886","article-title":"Selling sickness: the pharmaceutical industry and disease mongering.","volume":"324","author":"Moynihan","year":"2002","journal-title":"BMJ"},{"key":"R42-21-20210212","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1371\/journal.pmed.0030191","article-title":"The fight against disease mongering: generating knowledge for action.","volume":"3","author":"Moynihan","year":"2006","journal-title":"PLoS Med"},{"key":"R45-21-20210212","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jss.2006.10.010","article-title":"The devil is in the details: the pharmaceutical industry\u2019s use of gifts to physicians as marketing strategy.","volume":"140","author":"McFadden","year":"2007","journal-title":"J Surg Res"},{"key":"R46-21-20210212","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.amjmed.2005.02.031","article-title":"Do drug samples influence resident prescribing behavior? A randomized trial.","volume":"118","author":"Adair","year":"2005","journal-title":"Am J Med"},{"key":"R47-21-20210212","first-page":"729","article-title":"Effect of antihypertensive samples on physician prescribing patterns.","volume":"34","author":"Boltri","year":"2002","journal-title":"Fam Med"},{"key":"R48-21-20210212","doi-asserted-by":"crossref","first-page":"284","DOI":"10.2105\/AJPH.2007.114249","article-title":"Characteristics of recipients of free prescription drug samples: a nationally representative analysis.","volume":"98","author":"Cutrona","year":"2008","journal-title":"Am J Public Health"},{"key":"R49-21-20210212","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/0306312704043029","article-title":"Attention to \u2018details\u2019: etiquette and the pharmaceutical salesman in postwar American.","volume":"34","author":"Greene","year":"2004","journal-title":"Soc Stud Sci"},{"key":"R50-21-20210212","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/01.AOG.0000268800.46677.14","article-title":"The high cost of free lunch.","volume":"110","author":"Wall","year":"2007","journal-title":"Obstet Gynecol"},{"key":"R51-21-20210212","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1001\/jama.283.3.373","article-title":"Physicians and the pharmaceutical industry: is a gift ever just a gift?","volume":"283","author":"Wazana","year":"2000","journal-title":"JAMA"},{"key":"R52-21-20210212","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1001\/jama.286.9.1024-a","article-title":"Pharmaceutical branding of resident physicians.","volume":"286","author":"Sigworth","year":"2001","journal-title":"JAMA"},{"key":"R53-21-20210212","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1056\/NEJMsa064508","article-title":"A national survey of physician-industry relationships.","volume":"356","author":"Campbell","year":"2007","journal-title":"N Engl J Med"},{"key":"R54-21-20210212","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/archfami.3.4.327","article-title":"The role and value of pharmaceutical marketing.","volume":"3","author":"Levy","year":"1994","journal-title":"Arch Fam Med"},{"key":"R55-21-20210212","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1001\/jama.1995.03520400066047","article-title":"The accuracy of drug information from pharmaceutical sales representatives.","volume":"273","author":"Ziegler","year":"1995","journal-title":"JAMA"},{"key":"R56-21-20210212","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1056\/NEJM200006223422509","article-title":"The pharmaceutical industry\u2014to whom is it accountable?","volume":"342","author":"Angell","year":"2000","journal-title":"N Engl J Med"},{"key":"R57-21-20210212","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1046\/j.1525-1497.1998.00048.x","article-title":"A comparison of physicians\u2019 and patients\u2019 attitudes toward pharmaceutical industry gifts.","volume":"13","author":"Gibbons","year":"1998","journal-title":"J Gen Intern Med"},{"key":"R58-21-20210212","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1136\/bmj.326.7403.1352-a","article-title":"Readers want transparency in link between doctors and drug firms.","volume":"326","author":"Eaton","year":"2003","journal-title":"BMJ"},{"key":"R59-21-20210212","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0002-9343(01)00660-X","article-title":"Of principles and pens: attitudes and practices of medicine housestaff toward pharmaceutical industry promotions.","volume":"110","author":"Steinman","year":"2001","journal-title":"Am J Med"},{"key":"R60-21-20210212","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1001\/archinte.163.18.2213","article-title":"Are gifts from pharmaceutical companies ethically problematic? A survey of physicians.","volume":"163","author":"Brett","year":"2003","journal-title":"Arch Intern Med"},{"key":"R61-21-20210212","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1136\/jme.2005.014480","article-title":"Interactions of doctors with the pharmaceutical industry.","volume":"32","author":"Morgan","year":"2006","journal-title":"J Med Ethics"},{"key":"R62-21-20210212","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1162\/15265160360706552","article-title":"All gifts large and small: toward an understanding of the ethics of pharmaceutical industry gift-giving.","volume":"3","author":"Katz","year":"2003","journal-title":"Am J Bioeth"},{"key":"R63-21-20210212","article-title":"The Gift: the Form and Reason for Exchange in Archaic Societies.","author":"Mauss","year":"1990"},{"key":"R64-21-20210212","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1162\/15265160360706633","article-title":"Pens and other pharmaceutical industry gifts.","volume":"3","author":"Brody","year":"2003","journal-title":"Am J Bioeth"},{"key":"R65-21-20210212","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1162\/15265160360706598","article-title":"Cheap trinkets, effective marketing: small gifts from drug companies to physicians.","volume":"3","author":"Brett","year":"2003","journal-title":"Am J Bioeth"},{"key":"R66-21-20210212","doi-asserted-by":"crossref","first-page":"W30","DOI":"10.1162\/15265160360706813","article-title":"Large or small, a gift is a gift is a gift.","volume":"3","author":"Paris","year":"2003","journal-title":"Am J Bioeth"},{"key":"R67-21-20210212","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3109\/10401230109148963","article-title":"Newly admitted psychiatric patient prescriptions and pharmaceutical sales visits.","volume":"13","author":"Schwartz","year":"2001","journal-title":"Ann Clin Psychiatry"},{"key":"R68-21-20210212","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1001\/jama.1994.03510330062035","article-title":"Physicians\u2019 behavior and their interactions with drug companies. A controlled study of physicians who requested additions to a hospital drug formulary.","volume":"271","author":"Chren","year":"1994","journal-title":"JAMA"},{"key":"R69-21-20210212","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ajog.2004.09.026","article-title":"Current cervical neoplasia screening practices of obstetrician\/gynecologists in the US.","volume":"192","author":"Saint","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"R70-21-20210212","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/bmj.39196.740995.BE","article-title":"Accuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening: randomised controlled trial.","volume":"335","author":"Ronco","year":"2007","journal-title":"BMJ"},{"key":"R71-21-20210212","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/01.AOG.0000296488.85807.b3","article-title":"Liquid compared with conventional cervical cytology: a systematic review and meta-analysis.","volume":"111","author":"Arbyn","year":"2008","journal-title":"Obstet Gynecol"},{"key":"R72-21-20210212","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/01.AOG.0000298948.65284.d5","article-title":"Evidence-based medicine versus liquid-based cytology.","volume":"111","author":"Sawaya","year":"2008","journal-title":"Obstet Gynecol"},{"key":"R73-21-20210212","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1001\/jama.299.9.1060","article-title":"Financial support of continuing medical education.","volume":"299","author":"Steinbrook","year":"2008","journal-title":"JAMA"},{"key":"R74-21-20210212","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1056\/NEJMp048322","article-title":"Commercial support and continuing medical education.","volume":"352","author":"Steinbrook","year":"2005","journal-title":"N Engl J Med"},{"key":"R76-21-20210212","doi-asserted-by":"crossref","first-page":"e134","DOI":"10.1371\/journal.pmed.0040134","article-title":"Characteristics and impact of drug detailing for gabapentin.","volume":"4","author":"Steinman","year":"2007","journal-title":"PLoS Med"},{"key":"R77-21-20210212","article-title":"Committee Staff Report to the Chairman and Ranking Member: Use of Educational Grants by Pharmaceutical Manufacturers.","year":"2007"},{"key":"R79-21-20210212","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1378\/chest.102.1.270","article-title":"The effects of pharmaceutical firm enticements on physician prescribing patterns. There\u2019s no such thing as a free lunch.","volume":"102","author":"Orlowski","year":"1992","journal-title":"Chest"},{"key":"R80-21-20210212","first-page":"1233","article-title":"Management of Herpes in Pregnancy. ACOG Practice Bulletin No. 82. American College of Obstetricians and Gynecologists.","volume":"109","year":"2007","journal-title":"Obstet Gyonecol"},{"key":"R81-21-20210212","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/01.AOG.0000180779.35572.3a","article-title":"Genital herpes complicating pregnancy.","volume":"106","author":"Brown","year":"2005","journal-title":"Obstet Gynecol"},{"key":"R82-21-20210212","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/j.ajog.2005.07.041","article-title":"Risk factors for herpes simplex virus transmission to pregnant women: a couples study.","volume":"193","author":"Gardella","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"R86-21-20210212","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1353\/pbm.2007.0009","article-title":"Ghost marketing: pharmaceutical companies and ghostwritten journal articles.","volume":"50","author":"Moffatt","year":"2007","journal-title":"Perspect Biol Med"},{"key":"R87-21-20210212","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1136\/bmj.326.7400.1167","article-title":"Pharmaceutical industry sponsorship and research outcome and quality: systematic review.","volume":"326","author":"Lexchin","year":"2003","journal-title":"BMJ"},{"key":"R88-21-20210212","first-page":"477","article-title":"Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials.","volume":"170","author":"Bhandari","year":"2004","journal-title":"CMAJ"},{"key":"R89-21-20210212","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJM199506083322301","article-title":"Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine\/Premenstrual Dysphoria Collaborative Study Group.","volume":"332","author":"Steiner","year":"1995","journal-title":"N Engl J Med"},{"key":"R90-21-20210212","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1001\/jama.299.15.1800","article-title":"Guest authorship and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation.","volume":"299","author":"Ross","year":"2008","journal-title":"JAMA"},{"key":"R91-21-20210212","doi-asserted-by":"crossref","first-page":"e138","DOI":"10.1371\/journal.pmed.0020138","article-title":"Medical journals are an extension of the marketing arm of pharmaceutical companies.","volume":"2","author":"Smith","year":"2005","journal-title":"PLoS Med"},{"key":"R92-21-20210212","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1001\/jama.280.3.222","article-title":"Prevalence of articles with honorary authors and ghost authors in peer-reviewed medical journals.","volume":"280","author":"Flanagin","year":"1998","journal-title":"JAMA"},{"key":"R95-21-20210212","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00192-007-0330-z","article-title":"Lessons from the past: directions for the future. Do new marketed surgical procedures and grafts produce ethical, personal liability, and legal concerns for physicians?","volume":"18","author":"Ostergard","year":"2007","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"R98-21-20210212","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/AOG.0b013e318169f712","article-title":"Relationships with industry. ACOG Committee Opinion No. 401.","volume":"111","year":"2008","journal-title":"Obstet Gynecol"},{"key":"R99-21-20210212","article-title":"Code on Interactions with Healthcare Professionals.","year":"2002"},{"key":"R100-21-20210212","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1001\/jama.295.4.429","article-title":"Health industry practices that create conflicts of interest: a policy proposal for academic medical centers.","volume":"295","author":"Brennan","year":"2006","journal-title":"JAMA"},{"key":"R103-21-20210212","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/0002-9343(82)90911-1","article-title":"Scientific versus commercial sources of influence on the prescribing behavior of physicians.","volume":"73","author":"Avorn","year":"1982","journal-title":"Am J Med"},{"key":"R104-21-20210212","article-title":"Kohl Hearing Seeks Alternative to Drug Industry\u2019s Controversial Practice of Educating Doctors about New Drugs.","year":"2008"},{"key":"R105-21-20210212","article-title":"ACCME Standards for Commercial Support.","year":"2007"},{"key":"R106-21-20210212","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1001\/jama.297.11.1216","article-title":"Pharmaceutical company payments to physicians: early experiences with disclosure laws in Vermont and Minnesota.","volume":"297","author":"Ross","year":"2007","journal-title":"JAMA"},{"key":"R107-21-20210212","article-title":"The Future of Drug Safety: Promoting and Protecting the Health of the Public.","year":"2007"},{"key":"R108-21-20210212","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/01.ACM.0000232408.12648.5a","article-title":"Residents\u2019 perceptions over time of pharmaceutical industry interactions and gifts and the effect of an educational intervention.","volume":"81","author":"Schneider","year":"2006","journal-title":"Acad Med"}],"container-title":["Obstetrical & Gynecological Survey"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00006254-200809000-00021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:28:37Z","timestamp":1618036117000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006254-200809000-00021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":80,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/ogx.0b013e31817f1585","relation":{},"ISSN":["0029-7828"],"issn-type":[{"value":"0029-7828","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}